We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Stem Cell Activation Technique Works Well in Tissue Cultures

By LabMedica International staff writers
Posted on 11 Nov 2008
A novel method for covalently binding a specific sugar molecule to the surface of mesenchymal stem cell (MSCs) is designed to induce the stem cells to leave the blood stream and migrate to sites of injury where they can differentiate to replace damaged tissue.

Investigators at the Harvard-MIT Division of Health Sciences and Technology (Cambridge, MA, USA focused on one of the main unsolved problems in the field of stem cell therapy: "Delivery remains one of the biggest hurdles to stem cell therapy,” explained senior instructor Dr. More...
Jeffrey Karp. "The blood stream offers a natural delivery vehicle, but stem cells do not move through blood vessels normally after being expanded in culture.”

Dr. Karp is senior author on a paper published in the October 31, 2008, online edition of the journal Bioconjugate Chemistry that described a method for chemically modifying the surface of MSCs to induce them to travel to their intended targets.

The method is based on three components: avidin, biotin, and a tetrasaccharide carbohydrate called SLeX (Sialyl LewisX). SLeX is usually attached to O-glycans on the surface of cells, and is known to play a vital role in cell-cell recognition processes. It is one of the most important blood group antigens and is displayed on the terminus of glycolipids that are present on the cell-surface. Resting T and B-lymphocytes lack its expression and they are induced to strongly express SLeX upon activation. MSCs do not display SLeX on their cell surface.

The activation technique involved flooding a culture dish of MSCs with the three molecules--biotin, streptavidin, and SleX--one after the other. The biotin formed a strong bond with the streptavidin, and the complex anchored SLeX to the cell surface. The concentrations of each molecule were adjusted to maximize the cell's ability to roll along the interior of blood vessels, rather than getting lost in the flow.

The technique worked well in tissue culture; "We need to confirm that this rolling behavior translates into increased homing and tissue repair,” said Dr. Karp. "We may need to tweak the cells further.”

Related Links:

Harvard-MIT Division of Health Sciences and Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.